PX1 Research provides researchers and academic institutions with high-purity Selank 10mg for in vitro and preclinical investigation. Manufactured in GMP-compliant USA facilities, every lot undergoes rigorous third-party analytical testing to guarantee sequence identity, high purity, and minimal endotoxin levels.
PX1 Research provides researchers and academic institutions with high-purity Selank 10mg for in vitro and preclinical investigation. Manufactured in GMP-compliant USA facilities, every lot undergoes rigorous third-party analytical testing to guarantee sequence identity, high purity, and minimal endotoxin levels.
Researchers seeking to buy Selank 10mg for laboratory applications require analytical-grade, highly purified material to ensure experimental reproducibility in preclinical models. PX1 Research supplies USA-manufactured Selank 10mg lyophilized peptide verified via RP-HPLC and mass spectrometry to exceed 98% purity. Each lot undergoes rigorous third-party ISO 17025 laboratory testing for sequence integrity, peptide content, and low endotoxin levels strictly for research use.
When purchasing reagents for specialized neurochemical and immunological assays, sample consistency is critical. Impurities or degraded fragments can obscure receptorial binding kinetics and alter cellular signaling cascades. By securing Selank 10mg through PX1 Research, laboratory investigators receive fully traceable, lot-numbered vials complete with analytical documentation. You can also review our complete research peptide catalog to source complementary compounds for comparative studies.
Selank is a synthetic heptapeptide derivative of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg). To enhance metabolic stability against circulating peptidases, researchers modified the native tetrapeptide by appending a Pro-Gly-Pro tripeptide sequence to its C-terminus, resulting in the primary amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. This structural modification significantly extends the peptide's half-life in biological substrates while preserving its regulatory dynamics.
In biochemical literature, Selank is classified as a regulatory peptide that bridges central nervous system signaling and immune function. The addition of the C-terminal Pro-Gly-Pro motif protects the molecule from rapid degradation by carboxypeptidases and aminopeptidases. As a result, in vitro and ex vivo models demonstrate prolonged interaction times with targeted receptor complexes and metabolic enzymes compared to unmodified endogenous fragments.
Preclinical studies suggest that Selank acts as an allosteric modulator of the gamma-aminobutyric acid (GABA) receptor system. Rather than binding directly to the primary GABA recognition site as a classical agonist, evidence indicates that Selank alters receptor affinity and subunit expression patterns. In vitro binding assays demonstrate that the peptide can influence the affinity of GABA_A receptors for specific ligands without inducing direct chloride channel opening in the absence of endogenous GABA.
Furthermore, transcriptomic analyses in rodent neuronal cultures reveal that exposure to Selank alters the expression of genes encoding various GABA_A receptor subunits. This regulatory modulation suggests a complex mechanism by which the peptide helps maintain homeostasis within inhibitory neurotransmitter circuits under cellular stress conditions. Investigators examining neurochemical pathway dynamics utilize these findings to model peptidergic modulation of central inhibitory tone.
In addition to its interactions with GABAergic signaling, animal studies indicate that Selank influences central serotonergic metabolism. Research involving rodent brain tissue homogenates demonstrates that administration of the peptide alters serotonin (5-HT) synthesis and metabolite turnover rates, particularly within the hippocampus and hypothalamus. These observations point toward a multi-targeted neurochemical profile that modulates monoaminergic transmission during environmental or biochemical stress.
Another documented mechanism involves the inhibition of endogenous enkephalin-degrading enzymes. In vitro enzymatic assays show that Selank suppresses the activity of neutral endopeptidase (EC 3.4.24.11) and aminopeptidase N, enzymes responsible for the cleavage of endogenous opioid peptides such as leu-enkephalin and met-enkephalin. By inhibiting these degradation pathways, Selank elevates stable concentrations of endogenous regulatory peptides in ex vivo preparations, providing a useful model for studying neuropeptide preservation.
Because Selank is structurally derived from the natural immunostimulatory peptide tuftsin, researchers actively investigate its effects on peripheral and central immune pathways. Preclinical models demonstrate that Selank modulates the expression of key cytokines, including interleukin-6 (IL-6), interleukin-10 (IL-10), and interferon-gamma (IFN-gamma). The peptide appears to exert a balancing effect on immune signaling, shifting cytokine profiles depending on the baseline inflammatory state of the cellular culture or animal model.
In rodent splenocyte cultures, exposure to Selank has been shown to alter gene expression patterns associated with innate immune responses and leukocyte activation. This dual neuro-immune regulatory capacity makes Selank a primary subject of study in neuroimmunology, where investigators analyze the bidirectional communication between the central nervous system and peripheral immune cascades. Detailed mechanistic overviews can be accessed through our dedicated neuroimmunology research library.
When designing preclinical protocols to evaluate regulatory neuropeptides, laboratory investigators frequently compare Selank against other synthetic analogs derived from endogenous peptide fragments. Understanding the functional distinctions between these compounds allows researchers to select the precise molecular tool for their specific signaling or behavioral models.
For example, while Selank is derived from the immunomodulatory fragment tuftsin and exhibits prominent GABAergic and cytokine-regulating activity, Semax 30mg is derived from adrenocorticotropic hormone (ACTH 4-10) and primarily influences brain-derived neurotrophic factor (BDNF) expression and melanocortin signaling. Similarly, researchers investigating sleep architecture and circadian signaling often evaluate DSIP alongside these regulatory fragments, while Noopept serves as a classic synthetic benchmark for central cognitive processing models. Below is a comparative overview of these benchmark research compounds:
At PX1 Research, quality control is the foundation of every product we provide to the scientific community. To ensure that every 10mg vial of Selank meets strict analytical criteria, raw synthesis products undergo rigorous purification followed by comprehensive quality testing. We perform reverse-phase high-performance liquid chromatography (RP-HPLC) to establish purity levels exceeding 98% and verify that no residual synthesis byproducts or truncated sequences remain in the final lot.
Sequence identity and exact molecular weight are confirmed through electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF-MS). A lot-specific Certificate of Analysis (COA) is generated for every batch, detailing the observed chromatographic retention time, mass spectra data, and total peptide content. These COAs are readily accessible to laboratory managers and procurement officers to support research compliance and protocol validation.
Bacterial endotoxins (lipopolysaccharides) represent a significant confounding variable in cell culture and animal tissue assays. Even trace quantities of endotoxins can activate Toll-like receptor 4 (TLR4), triggering non-specific inflammatory cytokine release that invalidates sensitive immunomodulatory or neurochemical measurements. PX1 Research enforces strict endotoxin control standards across all synthesized peptide lots.
Every batch of Selank 10mg is evaluated using the Limulus Amebocyte Lysate (LAL) chromogenic assay to guarantee that endotoxin levels remain far below established research thresholds (<0.01 EU/mg). Products are processed in ISO-certified, GMP-compliant cleanroom facilities using sterile filtration before lyophilization. This rigorous protocol ensures that the peptide is completely suitable for delicate in vitro cell culture, slice physiology, and animal model administration without introducing confounding inflammatory artifacts.
Selank 10mg is supplied as a sterile, lyophilized (freeze-dried) powder in sealed glass vials under vacuum or inert gas atmosphere. For laboratory reconstitution, researchers should utilize sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the planned assay. Standard aseptic techniques should be maintained throughout solvent addition.
To preserve the structural integrity of the peptide, the reconstitution diluent should be introduced gently along the inner glass wall of the vial rather than sprayed directly onto the lyophilized cake. Allow the vial to sit at room temperature for several minutes, gently swirling if necessary until full dissolution occurs; do not vortex vigorously, as mechanical shear forces can induce peptide aggregation or denaturation. Reconstituted solutions intended for short-term use should be aliquoted and stored at 2°C to 8°C, while long-term liquid storage requires freezing at -20°C or -80°C to minimize hydrolytic cleavage.
Lyophilized Selank 10mg vials should be stored upon arrival at -20°C in a desiccated, dark environment to ensure maximum chemical stability. Under these conditions, the un-reconstituted peptide remains stable for up to 24 months from the date of manufacture. Repeated freeze-thaw cycles of both the dry powder and reconstituted aliquots must be strictly avoided to prevent physical degradation and loss of functional potency.
PX1 Research operates dedicated dispatch facilities located in California and Arizona, enabling rapid, climate-controlled domestic shipping (same-day dispatch M–F for orders placed prior to cutoff times). Academic, corporate, and institutional facilities requiring bulk quantities, custom vial sizing, or specialized lot reservation can utilize our streamlined wholesale purchasing portal to establish enterprise accounts with dedicated quality support.
What is the primary purity level of PX1 Research Selank 10mg?
Every lot of Selank 10mg supplied by PX1 Research is verified via RP-HPLC to exceed 98% purity. Detailed chromatographic profiles and mass spectrometry identity verification data are published on the lot-specific Certificate of Analysis.
How should Selank 10mg be reconstituted for laboratory assays?
Reconstitution should be performed under aseptic conditions using sterile bacteriostatic water or phosphate-buffered saline (PBS). Reagent should be gently directed down the internal side of the glass vial and allowed to dissolve naturally without high-speed vortexing.
What endotoxin standards apply to PX1 Research peptides?
PX1 Research peptides undergo chromogenic LAL testing to verify endotoxin content below strictly controlled laboratory limits (<0.01 EU/mg), ensuring compatibility with sensitive cellular assays and animal models without triggering unwanted immune responses.
What is the molecular structure of Selank?
Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It combines the endogenous immunomodulatory tetrapeptide tuftsin with a C-terminal Pro-Gly-Pro tripeptide sequence that enhances metabolic stability.
How does Selank differ from Semax in preclinical research?
Selank is derived from tuftsin and primarily studied for its GABAergic, serotonergic, and cytokine-modulating properties. Semax is derived from ACTH (4-10) and is primarily studied for its BDNF-inducing and neuroprotective properties.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are synthesized in state-of-the-art, GMP-compliant facilities within the USA. Orders are fulfilled directly from our inventory centers in California and Arizona with same-day shipping available Monday through Friday.
What storage conditions are recommended for lyophilized Selank?
Unopened, lyophilized Selank 10mg vials should be stored long-term at -20°C in a dry, dark freezer. Reconstituted liquid aliquots should be kept at -20°C or -80°C to prevent hydrolysis and peptide degradation.
Can institutions order Selank 10mg in bulk for large-scale studies?
Yes, academic laboratories and institutional procurement officers can request bulk quantities, lot reservations, and volume pricing by establishing a lab account through the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.